Report overview
Glioblastoma also is known as glioblastoma multiforme, is a type of malignant brain tumor that develops from glial cells. It proliferates at a rapid rate and is difficult to cure however; the treatment drugs are often prescribed to ease the symptoms.
This report contains market size and forecasts of Glioblastoma Treatment Drugs in global, including the following market information:
Global Glioblastoma Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Glioblastoma Treatment Drugs Market Sales, 2017-2022, 2023-2028, (K Tons)
Global top five Glioblastoma Treatment Drugs companies in 2021 (%)
The global Glioblastoma Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
VEGF/VEGFR Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glioblastoma Treatment Drugs include Arbor Pharms LLC., Bristol-Myers Squibb Company, Emcure Pharmaceuticals Ltd., F. Hoffmann-La Roche AG, Merck & Co., Sandoz and Sigma-Tau Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Glioblastoma Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioblastoma Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Glioblastoma Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
VEGF/VEGFR Inhibitor
Alkylating Agents
Miscellaneous Antineoplastic
Global Glioblastoma Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Glioblastoma Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Cancer Research Organization
Long Term Care Center
Diagnostic Centers
Global Glioblastoma Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Glioblastoma Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glioblastoma Treatment Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Glioblastoma Treatment Drugs revenues share in global market, 2021 (%)
Key companies Glioblastoma Treatment Drugs sales in global market, 2017-2022 (Estimated), (K Tons)
Key companies Glioblastoma Treatment Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arbor Pharms LLC.
Bristol-Myers Squibb Company
Emcure Pharmaceuticals Ltd.
F. Hoffmann-La Roche AG
Merck & Co.
Sandoz
Sigma-Tau Pharmaceuticals
